Trials / Unknown
UnknownNCT05176704
Development and Validation of a Novel Functional Eye-Tracking Software Application for Alzheimer's Disease
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (estimated)
- Sponsor
- Innodem Neurosciences · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study aims to develop and validate a sensitive and non-invasive eye-tracking software application. This study will obtain participant responses to brief cognitive tests designed to evaluate several key functions known to be affected by Alzheimer's Disease and non-invasive eye movement measurements in response to visually presented stimuli during specifically designed eye-tracking tests. The study data will be used to develop machine learning algorithms and validate a software application intended to track the progressive component of Alzheimer's Disease and associated cognitive changes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Eye-Tracking | Eye-tracking technology and algorithms used to successfully capture and track eye movements using an electronic tablet and the embedded camera of the device. |
Timeline
- Start date
- 2022-04-15
- Primary completion
- 2024-03-03
- Completion
- 2024-03-03
- First posted
- 2022-01-04
- Last updated
- 2024-02-13
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05176704. Inclusion in this directory is not an endorsement.